These data demonstrate that C9orf72-631 leads to durable knockdown of pathogenic C9orf72 transcripts as well as a durable suppression of molecular signatures associated with C9-ALS/FTD in the cortex and spinal cord of C9BAC mice. The gene discussed is C9orf72; the disease is frontotemporal dementia.